Saiba Animal Health AG, founded in 2013 as a spin-off from the University of Zurich, Switzerland, has developed a broad and innovative pipeline of Virus-Like Particles (VLP)-based therapeutic vaccines targeting major unmet medical needs in veterinary medicine.

https://www.saiba-animalhealth.com/

Zurich

Saiba Animal Health AG

Boehringer Ingelheim International GmbH is a multinational pharmaceutical company that has transferred the rights of three anti-diabetes trademarks—Gibtulio, Gibtulio Met, and Ajaduo—to Lupin Limited.

https://www.boehringer-ingelheim.com/

Ingelheim am Rhein, Rhineland-Palatinate, Germany

Ingelheim am Rhein

Boehringer Ingelheim

Boehringer Ingelheim has completed the acquisition of Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With this acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category.

Boehringer Ingelheim acquires Saiba Animal Health AG to boost pet therapeutics R&D

Boehringer Ingelheim acquires Saiba Animal Health AG to boost pet therapeutics R&D

Company Info

Related People